Pluri Inc. Form 8-K Summary
Business Context and Reporting Period
Pluri Inc. (Nasdaq: PLUR), a Nevada corporation headquartered in Haifa, Israel, filed this Current Report on Form 8-K on August 28, 2026, regarding events occurring on August 26, 2026. The filing details the entry into a Material Definitive Agreement for a registered direct offering and a concurrent private placement.
Key Financial Metrics and Transaction Details
The filing does not provide historical revenue, profit, cash flow, or margin data. The primary financial metrics relate to the capital raise transaction:
- Securities Issued: 1,200,000 Common Shares and Pre-Funded Warrants to purchase 1,028,940 Common Shares.
- Offering Price: $1.50 per Common Share; $1.49999 per Pre-Funded Warrant.
- Concurrent Warrants: 2,228,940 Common Warrants issued to the Purchaser with an exercise price of $1.65 per share.
- Expected Net Proceeds: Approximately $2,984,808 after deducting placement agent fees and offering expenses.
- Placement Agent Fee: 6.50% of gross proceeds plus reimbursement of out-of-pocket expenses up to $50,000.
Material Changes and Transaction Structure
The Company entered into a Securities Purchase Agreement with an institutional investor. The transaction structure includes:
- Registered Direct Offering: Sale of Common Shares and Pre-Funded Warrants under an effective Form S-3 shelf registration.
- Concurrent Private Placement: Sale of Common Warrants exempt from registration under Section 4(a)(2) and Regulation D.
- Lock-Up Agreements: Directors and executive officers are restricted from selling securities for 45 days post-closing.
- Issuance Restrictions: The Company is restricted from issuing Common Stock or equivalents for 45 days post-closing and from engaging in Variable Rate Transactions for six months post-closing, with limited exceptions for "at the market" offerings after 30 days.
Outlook, Use of Proceeds, and Risks
Use of Proceeds: The Company intends to use the net proceeds for corporate development, general corporate purposes, and working capital.
Warrant Terms: Pre-Funded Warrants are immediately exercisable at $0.00001. Common Warrants are exercisable six months after issuance for a five-year period at $1.65 per share.
Risks and Contingencies: The Private Securities (Common Warrants) are unregistered and may not be offered or sold in the United States absent registration or an applicable exemption. The transaction is subject to customary conditions to closing.
Key Facts for Investor Verification
- Verify the final closing date and actual net proceeds received, as the filing states the closing is "expected" on August 28, 2026.
- Confirm the identity of the institutional Purchaser, which is not disclosed in the summary text.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific representations, warranties, and termination provisions.
- Monitor the Company's compliance with the 45-day lock-up period for insiders and the six-month restriction on Variable Rate Transactions.
- Assess the dilution impact of the 2,228,940 Common Warrants exercisable at $1.65, which is above the current offering price of $1.50.